7Baggers
 published on: 2025-09-30 06:05:51  newser.com Tue, 30 Sep 2025 11:05:51 GMT
 what is hc wainwright's forecast for pmvp fy2026 earnings?  MarketBeat Mon, 22 Sep 2025 05:49:21 GMT
 fy2026 earnings estimate for pmvp issued by hc wainwright  Defense World Mon, 22 Sep 2025 05:49:19 GMT
 published on: 2025-09-19 21:45:00  newser.com Sat, 20 Sep 2025 02:45:00 GMT
 orbimed advisors llc adjusts holdings in pmv pharmaceuticals inc  GuruFocus Thu, 18 Sep 2025 00:59:16 GMT
 aug drivers: can pmv pharmaceuticals inc. reach all time highs this year  خودرو بانک Wed, 17 Sep 2025 20:56:52 GMT
 published on: 2025-09-16 21:28:02  newser.com Wed, 17 Sep 2025 02:28:02 GMT
 published on: 2025-09-16 18:11:09  خودرو بانک Tue, 16 Sep 2025 14:45:06 GMT
 published on: 2025-09-15 22:32:49  newser.com Tue, 16 Sep 2025 03:32:49 GMT
 published on: 2025-09-15 05:57:33  newser.com Mon, 15 Sep 2025 10:57:33 GMT
 PMV Pharmaceuticals  The Pharma Letter Mon, 15 Sep 2025 00:11:44 GMT
 published on: 2025-09-14 05:20:44  newser.com Sun, 14 Sep 2025 10:20:44 GMT
 The week in pharma: action, reaction and insight – week to September 12  The Pharma Letter Sun, 14 Sep 2025 07:00:00 GMT
 published on: 2025-09-12 12:42:36  Newser Fri, 12 Sep 2025 17:42:36 GMT
 td cowen maintains pmv pharmaceuticals(pmvp.us) with buy rating  富途牛牛 Fri, 12 Sep 2025 11:20:43 GMT
 published on: 2025-09-11 23:08:00  Newser Fri, 12 Sep 2025 04:08:00 GMT
 pmv pharma leaps on promising rezatapopt monotherapy data  The Pharma Letter Thu, 11 Sep 2025 11:35:44 GMT
 PMV plots ovarian cancer filing after seeing midphase data  Fierce Biotech Wed, 10 Sep 2025 07:00:00 GMT
 PMV Pharmaceuticals Reports Promising Phase 2 Trial Results  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 PMV Pharmaceuticals stock rating reiterated at Buy by TD Cowen  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 Is PMV Pharmaceuticals Ready for a Bounce Back?  timothysykes.com Wed, 10 Sep 2025 07:00:00 GMT
 PMV’s rezatapopt wows in ovarian cancer in early phase II readout  BioWorld MedTech Wed, 10 Sep 2025 07:00:00 GMT
 TD Cowen Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating  富途牛牛 Wed, 10 Sep 2025 07:00:00 GMT
 pmv pharma reports 33% response rate in tp53 y220c mutation trial  Investing.com Wed, 10 Sep 2025 07:00:00 GMT
 pmv pharmaceuticals surges on positive cancer therapy trial data  TradingView Wed, 10 Sep 2025 07:00:00 GMT
 craig-hallum maintains pmv pharmaceuticals(pmvp.us) with buy rating  富途牛牛 Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 21:21:20  Newser Tue, 09 Sep 2025 02:21:20 GMT
 published on: 2025-08-31 16:26:20  Newser Sun, 31 Aug 2025 21:26:20 GMT
 published on: 2025-08-31 14:14:04  Newser Sun, 31 Aug 2025 19:14:04 GMT

PMV Pharmaceuticals, Inc
(NASDAQ:PMVP) 

PMVP stock logo

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and r...

Full Time Employees: 39
CEO: David H. Mack  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends